DMSO (dimethyl sulfoxide) is an inexpensive industrial solvent, also sold as topical gels and liquids and promoted for pain and inflammation. Its one approved medical use is a bladder treatment for a chronic painful bladder condition, unrelated to general health. No human data show longer life or more healthy years; topical pain relief is inconsistent. Garlic-like odor, skin irritation, and headache are well documented; product purity matters. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT | 10–30 U/L | Liver safety |
| AST | 10–30 U/L | Liver safety |
| eGFR and creatinine | eGFR 90 mL/min/1.73 m² or higher | Kidney clearance of DMSO |
| Complete blood count | Hemoglobin 13–16 g/dL; platelets 150–350 ×10⁹/L | Detect hemolysis (red blood cell breakdown) or bleeding tendency |
| Urinalysis | No blood or hemoglobin | Detect hemolysis (red blood cell breakdown) after high-dose or infused exposure |
| Slit-lamp lens examination | No established target; track no new lens opacity or refractive shift from baseline | Animal lens changes prompted label advice |
| INR | Within the individual's prescribed target (for example 2.0–3.0 for warfarin) | Bleeding risk if on anticoagulants |
Cadence: Baseline before any sustained or repeated use; then at 4 weeks, at 3 months, and every 6 months while use continues, and sooner if allergy, bleeding, or vision changes appear